关于未来生物制造的思想来源.
1Institute of Biochemical Engineering/Institut für Bioverfahrenstechnik, University of Stuttgart, Stuttgart, Germany.
Microbial biotechnology
|January 13, 2025
概括
生物制造为面对气候变化的未来经济体提供了一条可持续的道路. 弥合创新差距对于将新型生物制造技术商业化和实现循环经济至关重要.
科学领域:
- 生物技术和可持续制造业的发展
- 循环经济原则循环经济原则
- 气候变化缓解缓解 气候变化缓解
背景情况:
- 增加的温室气体排放需要有弹性的经济解决方案.
- 生物制造是最大限度地减少环境影响的关键策略.
- 从实验室创新向商业生产的过渡面临着重大挑战.
研究的目的:
- 突出生物制造在应对气候变化的潜力.
- 确定克服创新"死亡谷"的关键步骤.
- 促进新型生物制造技术的开发和商业化.
主要方法:
- 这是一篇社论,概述了战略考虑.
- 它综合了生物制造当前的挑战和未来的机遇.
- 它的重点是弥合研究和工业应用之间的差距.
主要成果:
- 生物制造可以成为可持续循环经济的基石.
- 成功的商业化需要战略规划来克服创新障碍.
- 需要有利的条件才能让新的生物制造理念勃发展.
结论:
- 生物制造对于发展有弹性,面向未来的经济至关重要.
- 解决"创新的死亡谷"对于生物制造的成功至关重要.
- 需要进一步开发和支持才能充分发挥生物制造的潜力.
更多相关视频
相关概念视频
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
Bioplastics
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...


